With respect to gene therapy for ALS, the spinal injection of the AAV9 vector encoding shRNA to reduce synthesis of ALS-causing mutant SOD1 was reported in SOD1G37R mice, which demonstrated the improved survival by delaying the onset and slowing the progression of ALS [27]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.